trending Market Intelligence /marketintelligence/en/news-insights/trending/zhwv8txfnajhcxwgtvenrg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Sirtex takeover by CDH Investments gets Australian approval


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Sirtex takeover by CDH Investments gets Australian approval

Sirtex Medical Ltd. said a scheme of arrangement to be taken over by CDH Investments for A$33.60 per share has received Australian approval.

The scheme was granted clearance by the Australian Foreign Investment Review Board, satisfying a condition for the deal's implementation.

The transaction is still subject to other requirements, including U.S. antitrust approval.

On June 14, the Australian biotechnology company recommended a takeover bid by CDH and China Grand Pharmaceutical and Healthcare Holdings Ltd. to its shareholders — months after agreeing to be acquired by California's Varian Medical Systems Inc. for A$28 per share.